Parsons Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-61,050
Closed -$6.06M 361
2019
Q3
$6.06M Sell
61,050
-440
-0.7% -$41.8K 0.66% 31
2019
Q2
$5.68M Sell
61,490
-475
-0.8% -$45.1K 0.62% 36
2019
Q1
$5.85M Buy
61,965
+24,970
+67% +$2.18M 0.64% 34
2018
Q4
$2.37M Sell
36,995
-4,001
-10% -$295K 0.29% 84
2018
Q3
$3.67M Sell
40,996
-1,550
-4% -$137K 0.39% 63
2018
Q2
$3.38M Sell
42,546
-1,346
-3% -$112K 0.38% 65
2018
Q1
$3.92M Sell
43,892
-5,055
-10% -$485K 0.46% 52
2017
Q4
$5.11M Sell
48,947
-1,515
-3% -$171K 0.57% 41
2017
Q3
$7.36M Buy
50,462
+1,267
+3% +$173K 0.87% 22
2017
Q2
$6.39M Buy
49,195
+185
+0.4% +$22.7K 0.78% 25
2017
Q1
$6.1M Sell
49,010
-475
-1% -$56.8K 0.77% 29
2016
Q4
$5.73M Sell
49,485
-440
-0.9% -$49K 0.76% 31
2016
Q3
$5.22M Sell
49,925
-990
-2% -$107K 0.7% 35
2016
Q2
$5.02M Buy
50,915
+1,475
+3% +$153K 0.68% 37
2016
Q1
$4.95M Sell
49,440
-5,069
-9% -$522K 0.68% 38
2015
Q4
$6.53M Sell
54,509
-505
-0.9% -$58.4K 0.92% 20
2015
Q3
$5.95M Buy
55,014
+290
+0.5% +$36K 0.87% 20
2015
Q2
$6.33M Sell
54,724
-721
-1% -$82.4K 0.84% 20
2015
Q1
$6.39M Buy
55,445
+1,721
+3% +$206K 0.9% 18
2014
Q4
$6.01M Buy
53,724
+799
+2% +$84.3K 0.8% 26
2014
Q3
$5.01M Buy
52,925
+473
+0.9% +$42.7K 0.69% 32
2014
Q2
$4.5M Sell
52,452
-1,066
-2% -$81.1K 0.62% 40
2014
Q1
$3.73M Sell
53,518
-3,500
-6% -$277K 0.53% 48
2013
Q4
$4.82M Buy
57,018
+1,018
+2% +$80.6K 0.72% 35
2013
Q3
$4.32M Sell
56,000
-10,800
-16% -$757K 0.71% 35
2013
Q2
$3.91M Buy
+66,800
New +$4.02M 0.67% 37

Other funds holding CELG

Parsons Capital Management's CELG Position: Q4 2019 in Review

Parsons Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 61,050 shares — an estimated $6.06M sold.

Parsons Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.36M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Parsons Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Parsons Capital Management sold 61,050 Celgene Corp shares in Q4 2019, an estimated $6.06M.
  • Parsons Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Parsons Capital Management's Celgene Corp position peaked at $7.36M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.